Latest

Latest endometrial cancer News

  • Latest endometrial cancer news stories and updates. What is happening today? All recent endometrial cancer news and developments. Live coverage and timeline of endometrial cancer. All you need to know about endometrial cancer.
Imfinzi plus Imjudo combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolisation-eligible unresectable liver…
Imfinzi approved in the US in first and only immunotherapy combination for patients with BCG-naïve, high-risk non-muscle-invasive bladder cancer
More than $11 million awarded to improve cancer outcomes across NSW
From PCOS to PMOS: how a name change could improve health care for one in eight women
AstraZeneca to showcase Phase III data in liver, breast and bladder cancers and potential first-in-class rare disease therapy at ASCO 2026
More than $11 million awarded to improve cancer outcomes across NSW
Why has PCOS been given a new name?
Perioperative Imfinzi plus neoadjuvant EV showed statistically significant and clinically meaningful improvements in event-free survival and overall survival in muscle-invasive bladder cancer…
Imfinzi plus Imjudo combined with lenvatinib and TACE demonstrated a statistically significant and clinically meaningful improvement in progression-free survival in embolisation-eligible unresectable…
Research sheds light on key drivers of endometrial cancer
Contraceptive use: a catalyst for women’s health and socioeconomic empowerment
Population DNA screening for disease prevention: young adults at high genetic risk share their stories
New and expanded PBS listings for endometrial cancer, neuroblastoma, Parkinson’s disease and melanoma
As wrestling fans reel from the sudden death of Hulk Hogan, a cardiologist explains how to live long and healthy − and…
PCOS affects 1 in 8 women worldwide, yet it’s often misunderstood. A name change might help
Is there a link between menstrual health and pregnancy complications?
Cell atlas of the endometrium in women with PCOS may lead to better treatment
AI Diagnoses Major Cancer With Near Perfect Accuracy
Long-acting contraceptives seem to be as safe as the pill when it comes to cancer risk: new study
Prestigious National Health and Medical Research Council grants worth $3.74 million awarded to four QIMR Berghofer scientists
Cancer, birth defects and AI under the health microscope in 2025
UQ granted $6 million for two new Centres of Research Excellence
Weight-loss jabs linked to lower cancer risk compared with insulin – new study
Leading Cancer Researcher Faces Own Diagnosis
Australians Benefit From New Lifechanging Medicines Added To PBS
Cancer: here’s the role exercise plays, from prevention to treatment
Cancer often requires more than one treatment − an oncologist explains why some patients like Kate Middleton receive both chemotherapy and surgery
Kinder Test Could Improve Diagnosis Of Womb Cancer
New treatment for deadly uterine cancer
Imfinzi plus bevacizumab met primary endpoint for progression-free survival in liver cancer eligible for embolisation in EMERALD-1 Phase III trial
Imfinzi plus Lynparza reduced the risk of disease progression or death by 45% vs. chemotherapy in advanced or recurrent endometrial cancer
AstraZeneca advances scientific leadership across multiple cancers with first data from four pivotal Phase III trials at ESMO
Mater biobank donors lead fight against ovarian cancer
Common hormone could hold key to treating endometrial cancer
Trial to fill 30-year knowledge gap in cancer surgery
UQ clinical trials and cohort studies receive boost from NHMRC
Enhertu demonstrated clinically meaningful progression-free survival and overall survival across multiple HER2-expressing advanced solid tumours in DESTINY-PanTumor02 Phase II trial
New treatments for Australians with endometrial cancer and Lennox-Gastaut syndrome
Imfinzi plus Lynparza and Imfinzi alone both significantly improved progression-free survival in advanced endometrial cancer when added to chemotherapy
We need to talk about ovarian cancer, our deadliest gynaecological cancer
Funding boost for research into deadly cancers affecting women
Enhertu showed clinically meaningful and durable responses across multiple HER2-expressing tumour types in DESTINY-PanTumor02 Phase II trial
TGA Product Information safety updates 2 March
Jeannie Ferris Cancer Australia Recognition Award 10th anniversary recipients revealed
Early-career researchers boosted in mission to beat cancer
Novel blood test could quash endometrial cancer
Having more babies lowers risk of endometrial cancer
Imjudo in combination with Imfinzi approved in US for patients with unresectable liver cancer

© 2026 - The National Tribune Australia